High-dose therapy for indolent lymphomaMOUNIER, Nicolas; SOCIE, Gérard; GISSELBRECHT, Christian et al.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 225-239, issn 1040-8428Article

The role of high-dose chemotherapy in the treatment of non-small cell lung cancerFETSCHER, Sebastian.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 151-156, issn 1040-8428Article

Economic aspects of high-dose chemotherapy: a clinician's perspective reviewCETTO, Gian Luigi; MOLINO, Annamaria.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 251-267, issn 1040-8428Article

Tumor cell contamination in re-infused stem cell autografts : Does it have clinical significance?SHIMONI, Avichai; KÖRBLING, Martin.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 241-250, issn 1040-8428Article

High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT)BURDACH, S; JÜRGENS, H.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 169-189, issn 1040-8428Article

High-dose chemotherapy with autologous stem cell rescue for brain tumorsDUNKEL, Ira J; FINLAY, Jonathan L.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 197-204, issn 1040-8428Article

High-dose chemotherapy in adult soft tissue sarcomaREICHARDT, Peter.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 157-167, issn 1040-8428Article

Prognostic stratification in UPC: a role for assessing the value of conventional-dose and high-dose chemotherapy for unknown primary carcinomaSAAD, Everardo D; ABBRUZZESE, James L.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 205-211, issn 1040-8428Article